UCR identifies new tool to kill mosquitoes
Scientists have finally found malaria’s Achilles’ heel, a neurotoxin that isn’t harmful to any living thing except Anopheles mosquitoes that spread malaria.
Nearly half the world’s population lives in areas vulnerable to malaria which kills roughly 450,000 people per year, most of them children and pregnant women. Progress fighting the disease is threatened as Anopheles develop resistance to chemical insecticides used to control them. There is also great concern about toxic side effects of the chemicals.
About 30 years ago, scientists identified a strain of bacteria that kills Anopheles. Since the bacteria’s method of attack was not understood, it couldn’t be replicated or used as an alternative to chemical insecticides — until now.
An international team led by Sarjeet Gill, distinguished professor of molecular, cell and systems biology at UC Riverside, has identified a neurotoxin produced by the bacteria, and determined how it kills Anopheles. Their work is detailed in a paper published today in Nature Communications.
It took Gill and his team 10 years to achieve a breakthrough in their quest to understand the bacteria, and Gill attributes the success to modern gene sequencing techniques. They hit the bacteria with radiation, creating mutant bacterial strains that could not produce the toxin. By comparing the nontoxic strain to the one that kills Anopheles, they found proteins in the bacteria that are the keys to toxin production.
“Identifying the mechanisms by which the bacteria targets Anopheles has not been easy,” Gill said. “We were excited not only to find the neurotoxin, called PMP1, but also several proteins that likely protect PMP1 as it’s being absorbed in the mosquito’s gut.”
Many neurotoxins generally target vertebrates, and PMP1 bears 30 percent chemical similarity to botulinum or tetanus, both highly toxic to humans. Because the neurotoxin does not affect humans, vertebrates, fish, or even other insects, Gill believes the bacteria that produce PMP1 likely co-evolved along with Anopheles mosquitoes.
“It was surprising for us that PMP1 is not toxic to mice even by injection,” Gill said.
Members of Gill’s team include postdoctoral scholars Estefania Contreras, Jianwu Chen, Harpal Dhillon, and Nadia Qureshi as well as graduate student Swati Chawla from UC Riverside, Geoffrey Masuyer and Pål Stenmark from Stockholm University and Han Lim Lee from the Institute for Medical Research in Malaysia. Their work was funded by the U.S. National Institutes of Health.
The team has applied for a patent on this discovery, and now hopes to find partners that will help them develop their bacteria-based Anopheles insecticide. These findings also open the door to new avenues of research on additional environmentally friendly insecticides.
“There is a high likelihood that if PMP1 evolved to kill the Anopheles mosquito, there are other toxins that can kill other disease-spreading pests,” Gill said. “This could just be the start of a new way to prevent hundreds of thousands from getting sick and dying every year.”
Learn more: Controlling deadly malaria without chemicals
The Latest on: Malaria
via Google News
The Latest on: Malaria
- Africa: Responding to COVID-19 Must Not Come at the Expense of Malaria Activities, Otherwise Children May Pay The Priceon June 24, 2020 at 6:43 am
Opinion - Across the world, the COVID-19 pandemic has led people to fear accessing healthcare facilities. As a paediatrician working for Médecins Sans Frontières (MSF) in Sierra Leone, and with the ...
- Africa: Global Fund COVID-19 Report - Deaths From HIV, TB and Malaria Could Almost Double in 12 Months Unless Urgent Action Is Takenon June 24, 2020 at 6:03 am
A new report [ download in English ] released by the Global Fund today estimates that countries affected by HIV, tuberculosis and malaria urgently need US$28.5 billion to protect the extraordinary ...
- Mitigating the impact of COVID-19 on countries affected by HIV, tuberculosis and malariaon June 24, 2020 at 1:31 am
English Analysis on World and 6 other countries about Contributions, Disaster Management, Children, Women, Epidemic and more; published on 24 Jun 2020 by Global Fund ...
- Global Fund COVID-19 Report: Deaths from HIV, TB and Malaria Could Almost Double in 12 Months Unless Urgent Action is Takenon June 24, 2020 at 1:17 am
A new report released by the Global Fund today estimates that countries affected by HIV, tuberculosis and malaria urgently need US$28.5 ...
- Metabolic constraints on the B cell response to malariaon June 23, 2020 at 8:09 am
Early plasmablasts responding to Plasmodium infection may outcompete germinal center B cells for l-glutamine and delay pathogen control. Finally, we are currently experiencing a SARS-CoV-2 pandemic.
- Different distribution of malaria parasite in left and right extremities of vertebrate hosts translates into differences in parasite transmissionon June 23, 2020 at 2:16 am
The World Health Organisation estimates that in 2018, there were 228 million cases of malaria worldwide, resulting in more than 405 000 deaths 1. African countries are disproportionally affected, and ...
- Togolese league top scorer Koudagba dies of malariaon June 22, 2020 at 1:37 am
Koudagba was set to take another step in his career when he failed to pass the medical examination with the Tunisian club US Tataouine because of heart problems. "When he came back to Lomé, the ...
- U.S. halts clinical trial of anti-malaria drug hydroxychloroquine for coronavirus patientson June 20, 2020 at 1:08 pm
The study showed that the “” Hydroxychloroquine is an immunosuppressive drug normally used to treat malaria and rheumatoid conditions such as arthritis. It has been controversially touted by President ...
- Novartis halts malaria drug trial against COVID-19 amid participant shortfallon June 19, 2020 at 2:23 pm
Swiss drugmaker Novartis is halting its trial of malaria drug hydroxychloroquine (HCQ) against COVID-19 after struggling to find participants, it said on Friday, as data emerged from other studies ...
- Study on safety of malaria drugs for coronavirus retractedon June 19, 2020 at 3:30 am
Several authors of a large study that raised safety concerns about malaria drugs for coronavirus patients have retracted the report, saying independent reviewers were not able to verify information ...
via Bing News